Outsourcing STREAM

  1. Outsourcing Clinical Trial Disclosure Management 6/3/2020

    Deciding to outsource clinical trial disclosure management is a sponsor’s first step. Deciding what processes to outsource is the next step. Two study sponsors discuss with TrialScope what they outsource and why. Watch the short video.

  2. Trends In Sponsor-Of-Choice Initiatives: Consolidating Site Payments 5/5/2023

    Listen in as leaders from Bristol Myers Squibb, CenExel Centers of Excellence, and IQVIA Technologies discuss the importance of providing a consistent clinical trial payment experience to sites.

  3. See How You Can Start Your Early Phase Program 6-9 Weeks Earlier In Canada 3/23/2023

    Vice President of Business Development Lisa Sanford explains whether you need an IND before starting your first-in-human trial in Canada.

  4. Big Impact With A Personal Touch 1/30/2023

    Transforming lives. Improving human health. Bringing new therapies to life. Altasciences' CRO and CDMO services deliver.

  5. Getting Buy-In For Disclosure As A Service 6/3/2020

    Clinical trial disclosure teams often have a tough time convincing upper management on the benefits of Disclosure as a Service. Hear how two sponsors “sold” the idea of outsourcing this function. Watch the short TrialScope interview.

  6. How CROs Can Reduce Costs, Drive Retention And Become CRO Of Choice 1/17/2024

    In this inaugural Phireside webinar of 2024, speakers delve into the pivotal areas where CROs can enhance efficiency and cost-effectiveness.

  7. Navigating The Unique Attributes Of Psychedelic Drug Development 1/22/2024

    Join our panel of experts for an in-depth review of the FDA's guidance on psychedelic drug development, exploring necessary methodological adaptations for safety, pharmacology, and efficacy.

  8. Altasciences Clinical Services At A Glance 1/30/2023

    We can support your entire drug development program end to end, or you can partner with us for just one element. We offer you complete flexibility.

  9. How To Take Advantage Of Early Access Programs For The EU 6/12/2024

    Learn how to leverage Early Access Programs (EAPs) in the EU to expedite market entry for innovative life science products. Gain insights into running successful EAPs, including crucial steps for France.

  10. Streamlining Patient Access To Cell And Gene Therapies 12/21/2023

    Learn about the obstacles patients encounter when seeking CGTs and explore how technology and patient services can empower manufacturers and clinical teams to help patients overcome barriers.